ALK and non-small cell lung carcinoma: Kron Kron A A Alidousty Alidousty C C Scheffler Scheffler M M Impact of TP53 mutation status on systemic treatment outcome in ALK-rearranged non-small-cell lung cancer Impact of TP53 mutation status on systemic treatment outcome in ALK-rearranged non-small-cell lung cancer Ann Oncol : Off J Eur Soc Med Oncol Ann Oncol : Off J Eur Soc Med Oncol 2018 2018 29 29 2068 2068 2075 2075 10.1093/annonc/mdy333 10.1093/annonc/mdy333 Kron A, Alidousty C, Scheffler M et al (2018) Impact of TP53 mutation status on systemic treatment outcome in ALK-rearranged non-small-cell lung cancer.